Literature DB >> 2004254

Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat. Impaired motor readiness but preserved response preparation.

V J Brown1, T W Robbins.   

Abstract

Rats were trained to perform a visual spatial discrimination, where stimulus luminance provided information regarding the required direction of response. The visual stimuli were presented either in advance of a temporally unpredictable auditory imperative stimulus (simple reaction time condition) or simultaneously with the imperative stimulus (choice reaction time condition). Following unilateral striatal dopamine depletion, produced by intracerebral infusion of 6-hydroxydopamine, there was not only a marked spatial response bias towards the side of the dopamine depletion but also an abolition of the delay-dependent speeding of reaction time that reflects motor readiness, on the side contralateral to the lesion. Nevertheless, the rats continued to show a benefit in performance of the simple reaction time condition compared with the choice reaction time condition, indicating that they were able to use advance information to select and prepare responses. The results are discussed in the context of differential deficits shown by patients with Parkinson's disease in simple versus choice reaction time performance, and of the functions of parallel corticostriatal loops subserving the normal control of action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004254     DOI: 10.1093/brain/114.1.513

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

1.  NMDA, but not dopamine D(2), receptors in the rat nucleus accumbens areinvolved in guidance of instrumental behavior by stimuli predicting reward magnitude.

Authors:  W Hauber; I Bohn; C Giertler
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Central amygdalar and dorsal striatal NMDA receptor involvement in instrumental learning and spontaneous behavior.

Authors:  Matthew E Andrzejewski; Kenneth Sadeghian; Ann E Kelley
Journal:  Behav Neurosci       Date:  2004-08       Impact factor: 1.912

4.  Cognitive components of reaction time in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

5.  Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease.

Authors:  Nathalie Turle-Lorenzo; Nathalie Breysse; Christelle Baunez; Marianne Amalric
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

Review 6.  The nucleus accumbens as part of a basal ganglia action selection circuit.

Authors:  Saleem M Nicola
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

7.  Modulation of behavior by expected reward magnitude depends on dopamine in the dorsomedial striatum.

Authors:  Carsten Calaminus; Wolfgang Hauber
Journal:  Neurotox Res       Date:  2009-02-12       Impact factor: 3.911

8.  Disconnection of the entorhinal cortex and dorsomedial striatum impairs the sensitivity to instrumental contingency degradation.

Authors:  Bjoern Lex; Wolfgang Hauber
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

Review 9.  Establishing causality for dopamine in neural function and behavior with optogenetics.

Authors:  Elizabeth E Steinberg; Patricia H Janak
Journal:  Brain Res       Date:  2012-09-29       Impact factor: 3.252

10.  Asymmetries of visual attention after circumscribed subcortical vascular lesions.

Authors:  B Fimm; R Zahn; M Mull; S Kemeny; F Buchwald; F Block; M Schwarz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.